AbbVie

Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Allergan
AbbVie
presbyopia
clinical trials
AGN-190584
Flag link:
AbbVie’s Allergan Aesthetics brand gets a facelift
AbbVie’s Allergan Aesthetics brand gets a facelift
Fierce Pharma
AbbVie
Allergan
aesthetics
branding
Flag link:
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
Pharmaforum
Roche
Genentech
AbbVie
Venclexta
AML
clinical trials
FDA
Flag link:
4 AbbVie brands land on pharma's top TV spenders list for September
4 AbbVie brands land on pharma's top TV spenders list for September
Fierce Pharma
television ads
DTC ads
AbbVie
Humira
Skyrizi
Rinvoq
Ubrelvy
Flag link:
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Fierce Pharma
Ironwood
AbbVie
Linzess
IBS-C
FDA
Flag link:
Oxford University to test AbbVie's Humira as COVID-19 treatment
Oxford University to test AbbVie's Humira as COVID-19 treatment
Beckers Hospital Review
AbbVie
Humira
University of Oxford
clinical trials
COVID-19
Flag link:
Myovant shows disappointing prostate cancer data on the way to the FDA, stock sinks
Myovant shows disappointing prostate cancer data on the way to the FDA, stock sinks
Endpoints
Myovant
Relugolix
prostate cancer
AbbVie
Lupron
clinical trials
Flag link:
FDA fast-tracks AbbVie’s spinal injury drug
FDA fast-tracks AbbVie’s spinal injury drug
Pharmaforum
AbbVie
spinal injury
FDA
fast track
elezanumab
Flag link:
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
Fierce Pharma
drug pricing
regulatory
Celgene
Bristol-Myers Squibb
Teva Pharmaceutical
Amgen
Novartis
Mallinckrodt
AbbVie
US Congress
Flag link:
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Fierce Pharma
Eli Lilly
migraines
clinical trials
Reyvow
Biohaven
AbbVie
Flag link:
AbbVie has 47 reasons for its $2B cancer immunotherapy partnership with I-Mab
AbbVie has 47 reasons for its $2B cancer immunotherapy partnership with I-Mab
MedCity News
AbbVie
I-Mab Biopharma
Forty Seven
lemzoparlimab
cancer immunotherapy
Flag link:
AbbVie puts $2B on the table for I-Mab cancer collab as biotech nabs $418M raise
AbbVie puts $2B on the table for I-Mab cancer collab as biotech nabs $418M raise
Fierce Biotech
AbbVie
I-Mab Biopharma
R&D
biobucks
Flag link:
UroGen presses ahead with RTGel after Botox pairing stumbles in overactive bladder trial
UroGen presses ahead with RTGel after Botox pairing stumbles in overactive bladder trial
Fierce Pharma
Urogen
AbbVie
Jelmyto
overactive bladder
Flag link:
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
Fierce Pharma
AbbVie
Imbruvica
Humira
drug pricing
patents
Flag link:
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
Xconomy
AbbVie
Urogen
overactive bladder
Allergan
Botox
Flag link:
AbbVie Taps Harvard University for Viral Infection Research Partnership
AbbVie Taps Harvard University for Viral Infection Research Partnership
BioSpace
AbbVie
Harvard
R&D
viral infections
coronaviruses
hemorrhagic fever
Flag link:
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
Fierce Pharma
psoriasis
AbbVie
Skyrizi
Amgen
Celgene
Otezla
Flag link:
AbbVie options integrin-based compounds from Morphic, paving way for potential fibrosis treatments
AbbVie options integrin-based compounds from Morphic, paving way for potential fibrosis treatments
Endpoints
Morphic Therapeutics
AbbVie
idiopathic pulmonary fibrosis
Flag link:
AbbVie keeps TV ad lead in July, Roche and Pfizer follow in mildly curbed pharma TV market
AbbVie keeps TV ad lead in July, Roche and Pfizer follow in mildly curbed pharma TV market
Fierce Pharma
television ads
Roche
Pfizer
AbbVie
pandemic
DTC ads
COVID-19
Flag link:
The duvelisib hot potato is tossed to a new owner as Verastem looks to reorganize around the pipeline
The duvelisib hot potato is tossed to a new owner as Verastem looks to reorganize around the pipeline
Endpoints
duvelisib
Verastem
AbbVie
Flag link:

Pages